Matrix metalloproteinases in asthma and COPD.
暂无分享,去创建一个
[1] M. Sporn,et al. Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritis. , 2004, Clinical orthopaedics and related research.
[2] William C. Parks,et al. Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.
[3] L. Boulet,et al. Metalloproteinase-9 in Induced Sputum Correlates with the Severity of the Late Allergen-Induced Asthmatic Response , 2004, Respiration.
[4] J. Foidart,et al. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics , 2004, Laboratory Investigation.
[5] R. Sansores,et al. Matrix metalloproteinases activity in COPD associated with wood smoke. , 2004, Chest.
[6] V. Lagente,et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease , 2004, Inflammation Research.
[7] S. Wenzel,et al. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. , 2003, The Journal of allergy and clinical immunology.
[8] Y. Oh,et al. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. , 2003, Journal of Korean medical science.
[9] T. Koga,et al. Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma , 2003, Thorax.
[10] R. Pauwels,et al. Matrix Metalloproteinase-9-Mediated Dendritic Cell Recruitment into the Airways Is a Critical Step in a Mouse Model of Asthma1 , 2003, The Journal of Immunology.
[11] R. Buhl,et al. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. , 2003, Respiratory medicine.
[12] S. Wenzel,et al. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. , 2003, The Journal of allergy and clinical immunology.
[13] R. Visse,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[14] Z. Han,et al. Expression of matrix metalloproteinases MMP-9 within the airways in asthma. , 2003, Respiratory medicine.
[15] N. Jarjour,et al. Role of matrix metalloproteinases in asthma , 2003, Current opinion in pulmonary medicine.
[16] D. Nahm,et al. Metalloproteinase‐9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate‐induced asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[17] Richard J Martin,et al. Increased matrix metalloproteinase-9 with elastolysis in nocturnal asthma. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[18] K. Chung,et al. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. , 2002, Chest.
[19] J. Foidart,et al. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. , 2002, Chest.
[20] P. Barnes,et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory cell and molecular biology.
[21] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[22] N. Anthonisen,et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. , 2002, Human molecular genetics.
[23] V. Lagente,et al. Increased release of matrix metalloproteinase‐9 in the plasma of acute severe asthmatic patients , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[24] Hidetoshi Nakamura,et al. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. , 2001, Biochemical and biophysical research communications.
[25] Y. Rhee,et al. The involvement of matrix metalloproteinase‐9 in airway inflammation of patients with acute asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[26] J. D’Armiento,et al. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. , 2001, American journal of respiratory and critical care medicine.
[27] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[28] J. Foidart,et al. MMP-2- and MMP-9-Linked Gelatinolytic Activity in the Sputum from Patients with Asthma and Chronic Obstructive Pulmonary Disease , 2000, International Archives of Allergy and Immunology.
[29] W. Busse,et al. Increased matrix metalloproteinase-9 in the airway after allergen challenge. , 2000, American journal of respiratory and critical care medicine.
[30] M. Gaxiola,et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.
[31] D. Hartmann,et al. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. , 1999, American journal of respiratory and critical care medicine.
[32] T. Betsuyaku,et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1999, American journal of respiratory and critical care medicine.
[33] L. O’Driscoll,et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. , 1997, American journal of respiratory and critical care medicine.
[34] C. O'connor,et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. , 1997, Thorax.